1. Topically applied ascorbic acid solution for the treatment of basal cell carcinoma (BCC) 
Péter Holló, MD, PhD, Hajnalka Jókai, MD, PhD, Judit Hársing, MD, Gyöngyvér Soós, PhD, Sarolta Kárpáti, MD, PhD, Krisztián Németh, MD, PhD 
Journal of the American Academy of Dermatology 
Volume 75, Issue 1, Pages (July 2016)
DOI: /j.jaad
Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions

2. Fig 1
Clinical improvement of a nodular basal cell carcinoma (BCC). A, Marked clinical border of nodular BCC before therapy initiation. B, Red-labeled site of diagnostic punch biopsy (red arrow). C, Clinical picture of treated lesion before posttreatment biopsy. D, Post-therapy punch-biopsy (black arrow) and red marking of the first diagnostic punch-biopsy (red arrow). E, Clinical picture at 18-month follow-up visit.
Journal of the American Academy of Dermatology  , DOI: ( /j.jaad )
Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions

3. Fig 2
Histologic changes of a nodular basal cell carcinoma (BCC). Histology of a nodular BCC before therapy initiation (A) and tumor-free tissue at the end of the therapy (B). (Hematoxylin-eosin stain; original magnification: ×20.)
Journal of the American Academy of Dermatology  , DOI: ( /j.jaad )
Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions